{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:10:42Z","timestamp":1790115042373,"version":"4.0.1"},"reference-count":62,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Healthcare-associated infections (HAIs) caused by multidrug-resistant Klebsiella spp. represent a critical and escalating global public health threat. Carbapenem-resistant Klebsiella pneumoniae (CRKP) has been designated a critical-priority pathogen by the World Health Organization, and in the 2024 WHO Bacterial Priority Pathogens List, it was the top-ranked pathogen overall. The convergence of carbapenem resistance with hypervirulence in emerging strains has further complicated therapeutic decision-making. This review provides a narrative synthesis of the evidence published between 2020 and 2025 on the prevalence, resistance mechanisms, molecular epidemiology, clinical outcomes, and therapeutic strategies for Klebsiella pneumoniae infections acquired in healthcare settings, with particular attention to the Eastern European and Romanian context. PubMed\/MEDLINE, Embase, Web of Science, and the Cochrane Library were searched for relevant publications from January 2020 to June 2025, supplemented by WHO and ECDC surveillance reports. Studies were selected narratively for their relevance to the themes addressed. No new quantitative pooling was undertaken; all summary estimates reported below are cited from the published meta-analyses and surveillance reports that generated them. In the most recent global meta-analysis of hospital-acquired CRKP infection, which pooled 61 studies and 513,307 patients from 14 countries, the global prevalence of CRKP among nosocomial K. pneumoniae infections was 28.69% (95% CI: 26.53\u201330.86%), with pronounced regional variation from 14.29% in high-income North America to 66.04% in South Asia, and 42.05% in Western Europe. Pooled mortality among patients infected with CRKP has been estimated in a separate meta-analysis at 42.14%, compared with 21.16% among patients infected with carbapenem-susceptible strains, rising to 54.30% in bloodstream infections. Surveillance data place Romania third in Europe for carbapenem resistance among invasive K. pneumoniae isolates, at 50.30%, with a distinctive predominance of NDM plus OXA-48-like co-producers. Ceftazidime-avibactam is recommended for KPC- and OXA-48-producing strains, whereas metallo-beta-lactamase producers require aztreonam-containing combinations. CRKP in HAIs constitutes a global epidemiological emergency characterised by marked regional heterogeneity in carbapenemase distribution, high attributable mortality and rapidly evolving molecular profiles. Locally adapted surveillance, rapid molecular diagnostics, and stewardship programmes are required since empirical therapy cannot be standardised across regions.<\/jats:p>","DOI":"10.3390\/microorganisms14091870","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:03:41Z","timestamp":1787558621000},"page":"1870","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Carbapenem-Resistant Klebsiella pneumoniae in Healthcare-Associated Infections: Global and Regional Epidemiology, Resistance Mechanisms, and Therapeutic Strategies, with Particular Attention to Romania and Eastern Europe (2020\u20132025)"],"prefix":"10.3390","volume":"14","author":[{"given":"Oana-Elena","family":"Ioni\u0163\u0103","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Epidemiology, Faculty of Medicine, Ovidius University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Doctoral School, Faculty of Medicine, Ovidius University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Clinical Infectious Diseases Hospital, Ferdinand Blvd. No. 100, 900709 Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0567-4958","authenticated-orcid":false,"given":"Roxana-Carmen","family":"Cernat","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Epidemiology, Faculty of Medicine, Ovidius University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Clinical Infectious Diseases Hospital, Ferdinand Blvd. No. 100, 900709 Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4213-7378","authenticated-orcid":false,"given":"Nicola-Maria","family":"Militaru","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Epidemiology, Faculty of Medicine, Ovidius University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Doctoral School, Faculty of Medicine, Ovidius University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Clinical Infectious Diseases Hospital, Ferdinand Blvd. No. 100, 900709 Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Elena","family":"Vodarici","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Epidemiology, Faculty of Medicine, Ovidius University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Doctoral School, Faculty of Medicine, Ovidius University of Constanta, 1 University Alley, 900470 Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1992-1766","authenticated-orcid":false,"given":"Maria","family":"Fulina","sequence":"additional","affiliation":[{"name":"County Clinical Emergency Hospital \u201cSt. Apostle Andrew\u201d, Tomis Blvd. No. 145, 900591 Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4118-8268","authenticated-orcid":false,"given":"Daniela","family":"Pi\u021bigoi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology I, University of Medicine and Pharmacy \u201cCarol Davila\u201d, Bd. Eroii Sanitari 8, Sector 5, 050474 Bucharest, Romania"},{"name":"National Institute of Infectious Diseases \u201cProf. Dr. Matei Bal\u0219\u201d, 1 Dr. Calistrat Grozovici Street, District 2, 021105 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2386-543X","authenticated-orcid":false,"given":"Elena","family":"Mocanu","sequence":"additional","affiliation":[{"name":"Department of Public Health and Management, Faculty of Medicine, Ovidius University of Constanta, 1 University Alley, 900470 Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Severin","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Faculty of Medicine, Ovidius University of Constanta, 1 University Alley, 900470 Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4898-8938","authenticated-orcid":false,"given":"Claudia-Simona","family":"Cambrea","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Epidemiology, Faculty of Medicine, Ovidius University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Doctoral School, Faculty of Medicine, Ovidius University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Clinical Infectious Diseases Hospital, Ferdinand Blvd. No. 100, 900709 Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0395-6713","authenticated-orcid":false,"given":"Irina-Magdalena","family":"Dumitru","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Epidemiology, Faculty of Medicine, Ovidius University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Doctoral School, Faculty of Medicine, Ovidius University of Constanta, 1 University Alley, 900470 Constanta, Romania"},{"name":"Clinical Infectious Diseases Hospital, Ferdinand Blvd. No. 100, 900709 Constanta, Romania"},{"name":"Academy of Romanian Scientists, 3 Ilfov Street, 050044 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,23]]},"reference":[{"key":"ref_1","unstructured":"European Centre for Disease Prevention and Control (2024). Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals\u20142022\u20132023."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Cassini, A., Plachouras, D., Eckmanns, T., Abu Sin, M., Blank, H.-P., Ducomble, T., Haller, S., Harder, T., Klingeberg, A., and Sixtensson, M. (2016). Burden of six healthcare-associated infections on European population health: Estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002150"},{"key":"ref_3","unstructured":"European Centre for Disease Prevention and Control (2026, July 17). Healthcare-Associated Infections [Internet], Available online: https:\/\/www.ecdc.europa.eu\/en\/healthcare-associated-infections."},{"key":"ref_4","unstructured":"World Health Organization (2024). WHO Bacterial Priority Pathogens List 2024: Bacterial Pathogens of Public Health Importance."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1128\/AAC.01019-15","article-title":"Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance","volume":"59","author":"Pitout","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Song, H.W., Lin, Y., Wan, T.E., Yang, G.H., Jiang, M.T., Fu, B.H., and Pan, J.S. (2025). Global burden of Klebsiella pneumoniae infections and antimicrobial resistance in 2019. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-12120-w"},{"key":"ref_7","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators (2024). Global burden of bacterial antimicrobial resistance 1990\u20132021: A systematic analysis with forecasts to 2050. Lancet, 404, 1199\u20131226."},{"key":"ref_8","unstructured":"World Health Organization (2024). WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance."},{"key":"ref_9","unstructured":"European Centre for Disease Prevention and Control (2025). Antimicrobial Resistance in the EU\/EEA (EARS-Net)\u2014Annual Epidemiological Report for 2024."},{"key":"ref_10","unstructured":"European Centre for Disease Prevention and Control (2025). Carbapenem-Resistant Enterobacterales: Third Update."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Jin, C., Xiang, X., and Zhang, Q. (2026). Risk factors for carbapenem-resistant Klebsiella pneumoniae infection in hospitalized patients: A meta-analysis. Front. Cell Infect. Microbiol., 16.","DOI":"10.3389\/fcimb.2026.1717419"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"T\u0103l\u0103pan, D., Dan, M.O., Cire\u015f\u0103, A., and Rafila, A. (2026). Insights into Klebsiella pneumoniae carbapenem resistance\u2014A two-year retrospective study from a Romanian tertiary care hospital. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1728843"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Melinte, V., Radu, M.A., V\u0103c\u0103roiu, M.C., M\u00eerzan, L., Holban, T.S., Ileanu, B.V., Cismaru, I.M., and Gheorghi\u021b\u0103, V. (2025). Epidemiology of carbapenem-resistant Klebsiella pneumoniae co-producing MBL and OXA-48-like in a Romanian tertiary hospital: A call to action. Antibiotics, 14.","DOI":"10.3390\/antibiotics14080783"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jgar.2024.06.018","article-title":"Antibiotic resistance rates in hypervirulent Klebsiella pneumoniae strains: A systematic review and meta-analysis","volume":"38","author":"Beig","year":"2024","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Chen, J., Hou, Y., Shi, J., Gao, X., and Liang, G. (2025). Mortality risk of carbapenem-resistant hypervirulent Klebsiella pneumoniae vs. classical CR-KP: A systematic review and meta-analysis. Front. Public Health, 13.","DOI":"10.3389\/fpubh.2025.1680292"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1473-3099(21)00399-6","article-title":"Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): A prospective, multicentre, cohort study","volume":"22","author":"Wang","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13756-020-0686-0","article-title":"Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: A systematic review and meta-analysis","volume":"9","author":"Zhu","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/mdr.2017.0061","article-title":"Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: A meta-analysis","volume":"24","author":"Liu","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jgar.2019.09.006","article-title":"Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: A meta-analysis","volume":"21","author":"Li","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_20","unstructured":"European Centre for Disease Prevention and Control (2026, July 17). Surveillance Atlas of Infectious Diseases [Internet], Available online: https:\/\/atlas.ecdc.europa.eu."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lazar, D.S., Nica, M., Oprisan, C., Vlasie, M., Condurache, I.A., Florescu, S.A., and Gherlan, G.S. (2025). Emergence of carbapenem-resistant Klebsiella pneumoniae in a Romanian infectious diseases hospital. Pathogens, 14.","DOI":"10.3390\/pathogens14090859"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Vasile, C.C., Gheorghe, L.A., Chivu, C.D., Anghel, M.A.M., M\u00eeinea, \u0218.E., Pi\u021bigoi, D., and Cr\u0103ciun, M.D. (2024). Clostridioides difficile infections and antibiotherapy: Results of four years of observation in a Romanian tertiary hospital. Microorganisms, 12.","DOI":"10.3390\/microorganisms12122490"},{"key":"ref_23","unstructured":"European Centre for Disease Prevention and Control (2025). Antimicrobial Consumption in the EU\/EEA (ESAC-Net)\u2014Annual Epidemiological Report for 2024."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"ofad649","DOI":"10.1093\/ofid\/ofad649","article-title":"The global and regional prevalence of hospital-acquired carbapenem-resistant Klebsiella pneumoniae infection: A systematic review and meta-analysis","volume":"11","author":"Lin","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","article-title":"Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae","volume":"16","author":"Xu","year":"2017","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.2147\/IDR.S550953","article-title":"Epidemiological and antimicrobial resistance trends of Klebsiella pneumoniae pre-, during, and post-COVID-19 pandemic in a teaching hospital in Southwest China","volume":"18","author":"Du","year":"2025","journal-title":"Infect. Drug Resist."},{"key":"ref_27","first-page":"e92260","article-title":"Evolving patterns of etiological profiles and susceptibility trends of healthcare-associated infections since inception: A meta-analysis","volume":"17","author":"Khristi","year":"2025","journal-title":"Cureus"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1038\/s41467-024-49349-z","article-title":"International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe","volume":"15","author":"Kostyanev","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Chatzidimitriou, M., Voulgaridis, A., Tsolakidou, P., Chatzopoulou, F., Chonianakis, I., Vagdatli, E., Kachrimanidou, M., and Vyzantiadis, T.-A. (2025). Significant prevalence of dual KPC\/NDM carbapenemase-producing Klebsiella pneumoniae in an ICU cohort in Thessaloniki (2023), including an ST512 isolate co-harboring blaNDM-1 and blaKPC-3. Antibiotics, 14.","DOI":"10.3390\/antibiotics14100994"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e0359521","DOI":"10.1128\/mbio.03595-21","article-title":"MgrB-dependent colistin resistance in Klebsiella pneumoniae is associated with an increase in host-to-host transmission","volume":"13","author":"Bray","year":"2022","journal-title":"mBio"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1556\/030.2024.02230","article-title":"Carbapenem-resistant Klebsiella pneumoniae in the Balkans: Clonal distribution and associated resistance determinants","volume":"71","author":"Chatzidimitriou","year":"2024","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Pavlovi\u0107, D.B., Pospi\u0161il, M., Na\u0111, M., Mijatovi\u0107, V.V., Luxner, J., Zarfel, G., Grisold, A., Tonkovi\u0107, D., Dobri\u0107, M., and Bedeni\u0107, B. (2024). Multidrug-resistant bacteria in surgical intensive care units: Antibiotic susceptibility and beta-lactamase characterization. Pathogens, 13.","DOI":"10.3390\/pathogens13050411"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e0116921","DOI":"10.1128\/msystems.01169-21","article-title":"Specificities and commonalities of carbapenemase-producing Escherichia coli isolated in France from 2012 to 2015","volume":"7","author":"Cabanel","year":"2022","journal-title":"mSystems"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"24296","DOI":"10.1038\/s41598-024-74307-6","article-title":"Genetic characteristics of clinical carbapenem-resistant Klebsiella pneumoniae: Epidemic ST11 KPC-2-producing strains and non-negligible NDM-5-producing strains with diverse STs","volume":"14","author":"Yuan","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41564-024-01612-1","article-title":"Carbapenem-resistant Klebsiella pneumoniae capsular types, antibiotic resistance and virulence factors in China: A longitudinal, multi-centre study","volume":"9","author":"Hu","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Xie, X., Chen, J., Qi, L., Yuan, Y., Long, J., Wu, X., Liu, Y., Guo, J., Wang, C., and Meng, X. (2025). Global epidemiology and resistance-related mutations of ceftazidime-avibactam-resistant Klebsiella pneumoniae strains. Front. Cell Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1645042"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e0233824","DOI":"10.1128\/spectrum.02338-24","article-title":"Characterization of a blaKPC-3-carrying plasmid in a clinical isolate of Klebsiella pneumoniae belonging to the emerging successful clone ST147","volume":"13","author":"Recacha","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1093\/jac\/dkaa339","article-title":"Genomic background of the Klebsiella pneumoniae NDM-1 outbreak in Poland, 2012\u20132018","volume":"75","author":"Izdebski","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/jac\/dkac041","article-title":"Comparative phylogenomics of ESBL-, AmpC- and carbapenemase-producing Klebsiella pneumoniae originating from companion animals and humans","volume":"77","author":"Drapeau","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e0136923","DOI":"10.1128\/msystems.01369-23","article-title":"Outbreak of NDM-5-producing Klebsiella pneumoniae ST307: An emerging high-risk antimicrobial resistance clone in Shanghai, China","volume":"9","author":"Zhu","year":"2024","journal-title":"mSystems"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"801","DOI":"10.15537\/smj.2023.44.8.20230237","article-title":"Prevalence of extended-spectrum beta-lactamase and carbapenem-resistant Klebsiella pneumoniae in clinical samples","volume":"44","author":"Granov","year":"2023","journal-title":"Saudi Med. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/jac\/dks121","article-title":"OXA-48-like carbapenemases: The phantom menace","volume":"67","author":"Poirel","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_43","first-page":"000512","article-title":"BlaOXA-48-like genome architecture among carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the Netherlands","volume":"7","author":"Hendrickx","year":"2021","journal-title":"Microb. Genom."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/AAC.02573-14","article-title":"Comparative genomics of an IncA\/C multidrug resistance plasmid from Escherichia coli and Klebsiella isolates from intensive care unit patients and the utility of whole-genome sequencing in health care settings","volume":"58","author":"Hazen","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e01924-18","DOI":"10.1128\/AAC.01924-18","article-title":"Spreading patterns of NDM-producing Enterobacteriaceae in clinical and environmental settings in Yangon, Myanmar","volume":"63","author":"Sugawara","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"769","DOI":"10.21037\/atm-20-8216","article-title":"Carbapenemase detection by NG-Test CARBA 5\u2014A rapid immunochromatographic assay in carbapenem-resistant Enterobacterales diagnosis","volume":"9","author":"Zhu","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ferous, S., Anastassopoulou, C., Pitiriga, V., Vrioni, G., and Tsakris, A. (2024). Antimicrobial and diagnostic stewardship of the novel beta-lactam\/beta-lactamase inhibitors for infections due to carbapenem-resistant Enterobacterales species and Pseudomonas aeruginosa. Antibiotics, 13.","DOI":"10.3390\/antibiotics13030285"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Li, D., Huang, X., Rao, H., Yu, H., Long, S., Li, Y., and Zhang, J. (2023). Klebsiella pneumoniae bacteremia mortality: A systematic review and meta-analysis. Front. Cell Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1157010"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wang, B., Zhang, W., Zhang, H., Li, M., Zhang, Z., Peng, X., Wang, N., and Song, N. (2025). Comparative analysis of clinical characteristics and outcomes between carbapenem-resistant and carbapenem-sensitive Klebsiella pneumoniae infections: Insights from a tertiary hospital in Northern China. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1499057"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Chuang, C., Su, C.-F., Lin, J.-C., Lu, P.-L., Huang, C.-T., Wang, J.-T., Chuang, Y.-C., Siu, L.K., Fung, C.-P., and Lin, Y.-T. (2020). Does antimicrobial therapy affect mortality of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria? A nationwide multicenter study in Taiwan. Microorganisms, 8.","DOI":"10.3390\/microorganisms8122035"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Kong, W., Yang, X., Shu, Y., Li, S., Song, B., and Yang, K. (2023). Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1118307"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Herrera, F., Torres, D., Laborde, A., Jord\u00e1n, R., Ma\u00f1ez, N., Berruezo, L., Lambert, S., Suchowiercha, N., Costantini, P., and Nenna, A. (2024). Ceftazidime\u2013avibactam improves outcomes in high-risk neutropenic patients with Klebsiella pneumoniae carbapenemase-producing Enterobacterales bacteremia. Microorganisms, 12.","DOI":"10.3390\/microorganisms12010195"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.2147\/IDR.S475679","article-title":"Ceftazidime-avibactam for the treatment of carbapenem-resistant Klebsiella pneumoniae infection: A retrospective, single center study","volume":"17","author":"Yu","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S1473-3099(24)00499-7","article-title":"Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): A descriptive, multinational, open-label, phase 3, randomised trial","volume":"25","author":"Carmeli","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): A randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: The revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e01715-20","DOI":"10.1128\/AEM.01715-20","article-title":"Risk factors associated with carbapenemase-producing organism positivity in the hospital wastewater environment","volume":"86","author":"Park","year":"2020","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jhin.2020.07.017","article-title":"Toilet drain water as a potential source of hospital room-to-room transmission of carbapenemase-producing Klebsiella pneumoniae","volume":"106","author":"Heireman","year":"2020","journal-title":"J. Hosp. Infect."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"151339","DOI":"10.1016\/j.scitotenv.2021.151339","article-title":"Dissemination of carbapenem resistant bacteria from hospital wastewater into the environment","volume":"806","author":"Kehl","year":"2021","journal-title":"Sci. Total Environ."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e02711-21","DOI":"10.1128\/spectrum.02711-21","article-title":"Municipal wastewaters carry important carbapenemase genes independent of hospital input and can mirror clinical resistance patterns","volume":"10","author":"Szekeres","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Nasser-Ali, M., Aja-Macaya, P., Conde-P\u00e9rez, K., Trigo-Tasende, N., Rumbo-Feal, S., Fern\u00e1ndez-Gonz\u00e1lez, A., Bou, G., Poza, M., and Vallejo, J.A. (2024). Emergence of carbapenemase genes in Gram-negative bacteria isolated from the wastewater treatment plant in A Coru\u00f1a, Spain. Antibiotics, 13.","DOI":"10.3390\/antibiotics13020194"},{"key":"ref_62","first-page":"87","article-title":"Carbapenem-resistant bacteria in the environment","volume":"76","year":"2025","journal-title":"Arh. Hig. Rada Toksikol."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/9\/1870\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:19:25Z","timestamp":1787559565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/9\/1870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,23]]},"references-count":62,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["microorganisms14091870"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms14091870","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,23]]}}}